MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202521015408 A) filed by Rungta International Skills University; Rungta College Of Engineering & Technology; and Rungta College Of Pharmaceutical Sciences And Research on February 22, 2025, for Ai-Integrated Asthma Management Device With Real-Time Diagnostics And Targeted Therapy.
Inventors include Dr. Ajay Kushwaha; Raunit Kumar; Mahima Singh; Rama Jaiswal; Swati Kumari; Vivek Chouriya; Aditya Raj; Aman Kumar; and Abhinash Kumar.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: AI-Integrated Asthma Management Device with Real-Time Diagnostics and Targeted Therapy This invention describes an AI-driven device for personalized asthma management, integrating advanced diagnostics, precision medication delivery, and real-time environmental monitoring. The system features biosensors for measuring biomarkers such as exhaled nitric oxide (eNO) and lung function parameters, coupled with a micro-dosing nebulizer for dynamically calibrated medication administration. An environmental monitoring subsystem detects triggers like allergens, pollutants, and humidity changes, while an AI platform analyzes diagnostic and environmental data to provide predictive alerts, actionable insights, and personalized treatment recommendations. The device also includes a secure communication module for seamless integration with electronic health records (EHR) and healthcare provider dashboards, facilitating remote monitoring and collaborative care. Its portable, user-friendly design supports continuous operation with a rechargeable power source and ensures accessibility for all demographics. By combining real-time monitoring, predictive analytics, and tailored interventions, this invention addresses critical gaps in asthma care, improving outcomes and reducing healthcare burdens.
Disclaimer: Curated by HT Syndication.
